4//SEC Filing
Huizinga Robert Bindert 4
Accession 0001628280-21-009847
CIK 0001600620other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 5:22 PM ET
Size
6.9 KB
Accession
0001628280-21-009847
Insider Transaction Report
Form 4
Huizinga Robert Bindert
EVP of Research
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-05-11−40,000→ 0 totalExercise: $3.02Exp: 2021-03-30→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2021-05-11$3.02/sh+40,000$120,800→ 143,592 total
Footnotes (2)
- [F1]Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
- [F2]The shares subject to the options are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. The expiration date was extended as a result of the blackout period.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001837648
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 5:22 PM ET
- Size
- 6.9 KB